Trial Summary
What is the purpose of this trial?The purpose of this open label study is to evaluate longer term tolerability and early efficacy of transcranial ultrasound in the treatment of patients with refractory depression and anxiety.
Eligibility Criteria
This trial is for adults who have tried at least three antidepressants and anxiolytics without improvement, have a diagnosis of Major Depressive Disorder or Generalized/Acute Anxiety Disorder, and score high on anxiety and depression scales.Inclusion Criteria
I am 18 years old or older.
You have a score of more than 13 on a test called the Beck Depression Inventory.
I have tried 3 different anxiety medications without success.
+4 more
Participant Groups
The study is testing the use of transcranial focused ultrasound as a treatment. It's an open label study, meaning everyone knows they're getting the treatment, to see if it helps with severe depression and anxiety.
1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
All patients enrolled will receive transcranial focused ultrasound. Target location is dependent on patient condition.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Neurological Associates of West LASanta Monica, CA
Loading ...
Who Is Running the Clinical Trial?
Neurological Associates of West Los AngelesLead Sponsor